Claim: "Speaker Pelosi's drug pricing plan would siphon $1 trillion or more from biopharmaceutical innovators over the next 10 years. CBO's preliminary estimate found this bill 'would result in lower spending on research and development and thus reduce the introduction of new drugs.
Fact-check: Pharma on Pelosi drug bill: Fair warning or fearmongering?
Verdict: barely-true
Organisation: PolitiFact
Author: Shefali Luthra
Date published: 2019-12-05T00:00:00